To Take or Not to Take With Meals? Unraveling Issues Related to Food Effects Labeling for Oral Antineoplastic Drugs.

about

To Take or Not to Take With Meals? Unraveling Issues Related to Food Effects Labeling for Oral Antineoplastic Drugs.

Item

http://www.wikidata.org/entity/Q49350350

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

To Take or Not to Take With Me ...... for Oral Antineoplastic Drugs.

@en

To Take or Not to Take With Me ...... for Oral Antineoplastic Drugs.

@nl

type

Item

label

To Take or Not to Take With Me ...... for Oral Antineoplastic Drugs.

@en

To Take or Not to Take With Me ...... for Oral Antineoplastic Drugs.

@nl

prefLabel

To Take or Not to Take With Me ...... for Oral Antineoplastic Drugs.

@en

To Take or Not to Take With Me ...... for Oral Antineoplastic Drugs.

@nl

P1476

To Take or Not to Take With Me ...... for Oral Antineoplastic Drugs.

@en

P2093

Jiexin Deng

http://www.w3.org/2001/XMLSchema#string

Lawrence J Lesko

http://www.w3.org/2001/XMLSchema#string

Satjit S Brar

http://www.w3.org/2001/XMLSchema#string

P2860

Patient-reported preferences for oral versus intravenous administration for the treatment of cancer: a review of the literature.

Adherence to therapy with oral antineoplastic agents

Drug, meal and formulation interactions influencing drug absorption after oral administration. Clinical implications.

Inconsistent labeling of food effect for oral agents across therapeutic areas: differences between oncology and non-oncology products.

Prevalence of potential drug-drug interactions in cancer patients treated with oral anticancer drugs

Oral cancer chemotherapy: the critical interplay between patient education and patient safety.

Oral chemotherapy food and drug interactions: a comprehensive review of the literature.

Exposure-Response Analysis of Sonidegib (LDE225), an Oral Inhibitor of the Hedgehog Signaling Pathway, for Effectiveness and Safety in Patients With Advanced Solid Tumors.

Population pharmacokinetics of sonidegib (LDE225), an oral inhibitor of hedgehog pathway signaling, in healthy subjects and in patients with advanced solid tumors.

Effect of food on everolimus absorption: quantification in healthy subjects and a confirmatory screening in patients with renal transplants.

P31

scholarly article

P356

10.1002/CPDD.416

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29197167

http://www.w3.org/2001/XMLSchema#string

P921

food labeling